Related Experiment Video
Updated: Aug 12, 2025

Motor Dual-Tasks for Gait Analysis and Evaluation in Post-Stroke Patients
Published on: March 11, 2021
ADAMTS-13 activity in stroke of known and unknown cause: Relation to vascular risk factor burden
Gerrit M Grosse1, Andrei Leotescu1, Jan-Thorben Sieweke2
1Department of Neurology, Hannover Medical School, Hannover, Germany.
Insights
A disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13 (ADAMTS-13) activity is lower in patients with more vascular risk factors for stroke. This suggests ADAMTS-13 may play a role in cerebrovascular risk.
Area of Science:
- Neurology
- Vascular Biology
- Biochemistry
Background:
- Understanding ischemic stroke mechanisms is crucial for secondary prevention strategies.
- A disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13 (ADAMTS-13) possesses antithrombotic properties and is implicated in stroke pathophysiology.
- The association between ADAMTS-13 and stroke etiology, along with vascular risk factors, requires further investigation.
Purpose of the Study:
- To investigate the association between ADAMTS-13 activity and stroke etiology.
- To explore the relationship between ADAMTS-13 activity and the burden of vascular risk factors in stroke patients.
Main Methods:
- ADAMTS-13 activity was measured in two prospectively recruited stroke cohorts.
- Cohort 1 included patients with stroke due to ESUS, AF, large-artery atherosclerosis, or small vessel disease (n=88).
- Cohort 2 comprised patients with cryptogenic stroke and PFO undergoing PFO closure (n=38).
- Vascular risk factor burden was assessed using CHA2DS2VASC, ESRS, and RoPE scores.
Main Results:
- ADAMTS-13 activity was lower in AF-related stroke patients compared to ESUS patients, though this was confounded by vascular risk factors.
- ADAMTS-13 activity showed an inverse correlation with ESRS (r=-0.452, p<0.001) and CHA2DS2VASC (r=-0.375, p<0.001) in cohort 1.
- A positive correlation was observed between ADAMTS-13 activity and the RoPE score in cohort 2 (r=0.413, p=0.010).
Conclusions:
- ADAMTS-13 activity is inversely correlated with the number of vascular risk factors across various stroke etiologies.
- These findings suggest a potential role for ADAMTS-13 in mediating cerebrovascular risk.
- Further research is warranted to elucidate the precise role of ADAMTS-13 in stroke pathophysiology and prevention.
Background:
The identification of the underlying mechanism in ischemic stroke has important implications for secondary prevention. A disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13 (ADAMTS-13) has antithrombotic properties and was repeatedly implicated in the pathophysiology of stroke. In this study, we, therefore, aimed to investigate whether ADAMTS-13 is associated with stroke etiology and the burden of vascular risk factors.
Methods:
We determined ADAMTS-13 activity in two prospectively recruited stroke cohorts in the long-term course after the event. Cohort 1 (n = 88) consisted of patients who suffered a stroke due to embolic stroke of undetermined source (ESUS), cardioembolic stroke due to atrial fibrillation (AF), large-artery atherosclerosis, or small vessel disease. In cohort 2, patients with cryptogenic stroke and patent foramen ovale (PFO) scheduled for PFO closure (n = 38) were enrolled. As measures of vascular risk factor burden, the CHA2DS2VASC score, the Essen Stroke Risk Score (ESRS), and the Risk of Paradoxical Embolism (RoPE) score were calculated, as appropriate.
Results:
ADAMTS-13 activity was lower in patients with AF-related stroke compared to patients with ESUS (p = 0.0227), which was, however, due to confounding by vascular risk factors. ADAMTS-13 activity inversely correlated with the ESRS (r = -0.452, p < 0.001) and CHA2DS2VASC (r = -0.375, p < 0.001) in cohort 1. In accordance with these findings, we found a positive correlation between ADAMTS-13 activity and the RoPE score in cohort 2 (r = 0.413, p = 0.010).
Conclusion:
ADAMTS-13 activity is inversely correlated with the number of vascular risk factors across different stroke etiologies. Further study is warranted to establish ADAMTS-13 as a mediator of cerebrovascular risk.
Related Concept Videos
Atherosclerosis III: Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Atherosclerosis IV: Nursing Management
Peripheral Artery Disease III: Interprofessional Care

